European Journal of Surgical Oncology
Volume 33 , Pages S76-S83 , December 2007

Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour

  • G. Mentha

      Affiliations

    • Department of Surgery, University Hospital of Geneva, Geneva, Switzerland
    • Corresponding Author InformationCorresponding author: Units of Transplantation and Visceral Surgery, Department of Surgery, University Hospital of Geneva, 1211 Geneva 14, Switzerland. Tel.: +41 22 372 7607; fax: +41 22 372 7600.
    • ,
  • P. Majno

      Affiliations

    • Department of Surgery, University Hospital of Geneva, Geneva, Switzerland
    • ,
  • S. Terraz

      Affiliations

    • Department of Radiology, University Hospital of Geneva, Geneva, Switzerland
    • ,
  • L. Rubbia-Brandt

      Affiliations

    • Department of Pathology, University Hospital of Geneva, Geneva, Switzerland
    • ,
  • P. Gervaz

      Affiliations

    • Department of Surgery, University Hospital of Geneva, Geneva, Switzerland
    • ,
  • A. Andres

      Affiliations

    • Department of Surgery, University Hospital of Geneva, Geneva, Switzerland
    • ,
  • A.S. Allal

      Affiliations

    • Department of Radiology, University Hospital of Geneva, Geneva, Switzerland
    • ,
  • Ph. Morel

      Affiliations

    • Department of Surgery, University Hospital of Geneva, Geneva, Switzerland
    • ,
  • A.D. Roth

      Affiliations

    • Department of Oncology, University Hospital of Geneva, Geneva, Switzerland

,Accepted 26 September 2007.

References 

  1. Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?. J Clin Oncol. 2005;23:8490–8499
  2. De Gramont A, Figer A, Seymour M, et al. Leucovorin and Fluorouracil with or without Oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938–2947
  3. Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with Fluorouracil compared with Fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. Lancet. 2000;355:1041–1047
  4. Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224:509–520
  5. Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy. A contraindication to liver resection for multiple colorectal metastases?. Ann Surg. 2004;240:1052–1064
  6. Köhne CH, Van Cutsem E, Wils J, et al. Phase III study of weekly high-dose infusional Fluorouracil plus Folinic Acid with or without Irinotecan in patients with metastatic colorectal cancer: European Organisation for research and treatment of cancer gastrointestinal group study 40986. J Clin Oncol. 2005;23:4856–4865
  7. Giacchetti S, Perpoint B, Zidani R, et al. Phase III multicenter randomized trial of Oxaliplatin added to chronomodulated Fluorouracil-Leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol. 2000;18:136–147
  8. Falcone A, Masi G, Allegrini G, et al. Biweekly chemotherapy with Oxaliplatin, Irinotecan, infusional Fluorouracil, and Leucovorin: a pilot study in patients with metastatic colorectal cancer. J Clin Oncol. 2002;20:4006–4014
  9. Seium Y, Stupp R, Ruhstaller T, et al. Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I–II study. Ann Oncol. 2005;16:762–766
  10. Sheikh HY, Vall JW, Palmer K, et al. Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study. Br J Cancer. 2007;96:38–43
  11. Tabernero J, Rougier P, Lutz MP, et al. Eur J Cancer Suppl. 2005;3:181;[Abstract No. 642]
  12. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus Irinotecan, Fluorouracil and Leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335–2342
  13. Van Cutsem E. Progress with biological agents in metastatic colorectal cancer leads to many challenges. J Clin Oncol. 2006;24:3325–3327
  14. Portier G, Elias D, Bouche O, et al. Multicenter randomized trial of adjuvant Fluorouracil and Folinic Acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 TRIAL. J Clin Oncol. 2006;24:4976–4982
  15. Nordlinger B, Sorbye H, Debois M, et al. Feasibility and risks of pre-operative chemotherapy with Folfox 4 and surgery for resectable colorectal cancer liver metastases. Interim results of the EORTC intergroup randomized phase III study 40983. Proc Am Soc Clin Oncol. 2005;23:253s;Abstract 3528
  16. Gruenberger T, Sorbye H, Debois M, et al. Tumor response to pre-operative chemotherapy with Folfox-4 for resectable colorectal cancer liver metastases. Interim results of EORTC intergroup randomized phase III study 40983. Proc Am Soc Clin Oncol. 2006;24:146s;Abstract 3500
  17. Andres A, Majno P, Morel Ph, et al. Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score. Ann Surg Oncol 2007 Oct 2 [Epub ahead of print].
  18. Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460–466
  19. Vauthey JN, Pawlik TM, Ribeiro D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065–2072
  20. Elias D, Youseff O, Sideris L, et al. Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol. 2004;86:4–9
  21. Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure?. J Clin Oncol. 2006;24:3939–3945
  22. Rubbia-Brandt L, Giostra E, Brezault C, et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol. 2007;18:299–304
  23. Makuuchi M, Le Thai B, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521–527
  24. De Baere T, Roche A, Elias D, et al. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology. 1996;200:559–563
  25. Imamura H, Shimada R, Kubota M, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology. 1999;29:1099–1105
  26. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer. Surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–372
  27. Madoff DC, Abdalla EK, Gupta S, et al. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol. 2005;16:215–225
  28. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg. 2002;137:675–680
  29. Vauthey JN, Chaoui A, Do KA, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127:512–519
  30. Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol. 2005;16:779–790
  31. Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231:480–486
  32. Elias D, De Baere T, Roche A, Ducreux M, Leclere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg. 1999;86:784–788
  33. Kokudo N, Tada K, Seki M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology. 2001;34:267–272
  34. Elias D, Santoro R, Ouellet JF, Osmak L, De Baere T, Roche A. Simultaneous percutaneous right portal vein embolization and left liver tumour radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases. Hepatogastroenterology. 2004;51:1788–1791
  35. Terraz S, Constantin C, Majno P, Spahr L, Mentha G, Becker CD. Image-guided multipolar radiofrequency ablation of liver tumours: initial clinical results. Eur Radiol. 2007;17:2253–2261
  36. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234:961–967
  37. Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol. 2005;23:1358–1364
  38. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases form colorectal cancer: long-term results in 117 patients. Radiology. 2001;221:159–166
  39. de Baere T, Bessoud B, Dromain C, et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. Am J Roentgenol. 2002;178:53–59
  40. Elias D, Sideris L, Pocard M, Dromain C, De Baere T. Intraductal cooling of the main bile ducts during radiofrequency ablation prevents biliary stenosis. J Am Coll Surg. 2004;198:717–721
  41. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation. Multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242:158–171
  42. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–827
  43. Berney T, Mentha G, Morel Ph. Total vascular exclusion of the liver for the resection of lesions in contact with the vena cava or the hepatic veins. Brit J Surg. 1998;85:485–488
  44. Belghiti J, Hiramatsu K, Benoist S, Massault PF, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38–46
  45. Strong RW, Lynch SV, Wall DR, Ong TH. The safety of elective liver resection in a special unit. Aust N Z J Surg. 1994;64:530–534
  46. Choti MA, Bowman HM, Pitt HA, et al. Should hepatic resections be performed at high-volume referral centers?. J Gastrointest Surg. 1998;2:11–20
  47. Fong Y, Gonen M, Rubin D, Radzyner M, Brennan MF. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg. 2005;242:540–547
  48. Chowdhury MM, Dagash H, Pierro A. A systematic review of the impact of volume of surgery and specialization on patient outcome. Brit J Surg. 2007;94:145–161
  49. Kooby DA, Stockman J, Ben-Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg. 2003;237:860–869
  50. Nordlinger B, Guiget M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer. 1996;77:1254–1262
  51. Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg. 2000;231:743–751
  52. Thelen A, Jonas S, Benckert C, et al. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis. 2007;22:1269–1276
  53. Weber JC, Bachellier P, Oussoultzoglou E, Jaeck D. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg. 2003;90:956–962
  54. Chua HK, Sondenaa K, Tsiotos GG, Larson DR, Wolff BG, Nagorney DM. Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum. 2004;47:1310–1316
  55. Tanaka K, Shimada H, Matsuo K, et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery. 2004;136:650–659
  56. Minagawa M, Yamamoto J, Miwa S, et al. Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg. 2006;141:1006–1012
  57. Adam R. Colorectal cancer with synchronous liver metastases. Brit J Surg. 2007;94:129–131
  58. Quenet F, Nordlinger B, Rivoire M, et al. Resection of previously unresectable liver metastases from colorectal cancer after chemotherapy with CPT-11/L-OHP/LV5FU (Folfirinox): a prospective phase II trial. Proc Am Soc Clin Oncol. 2004;22:abstract 3613
  59. Cervantes A, Casado E, Van Cutsem E, et al. Phase II study with cetuximab plus folofox-4 in first-line setting for epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer. Proc ECCO. 2005;3:181;[Abstract 642]
  60. Chiappa A, Biffi R, Bertani E, et al. Surgical outcomes after total mesorectal excision for rectal cancer. J Surg Oncol. 2006;94:182–193
  61. Tran CL, Udani S, Holt A, Arnell T, Kumar R, Stamos MJ. Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer. Am J Surg. 2006;192:873–877
  62. Lipska M, Bissett IP, Parry BR, Merrie AEH. Anastomotic leakage after lower gastrointestinal anastomosis: men are at a higher risk. ANZ J Surg. 2006;76:579–585
  63. Matthiessen P, Hallböök O, Andersson M, Rutegard J, Sjödahl R. Risk factors for anastomotic leakage after anterior resection of the rectum. Colorectal Dis. 2004;6:462–469
  64. Mantion G, Panis Y. Mortalité et morbidité en chirurgie colo-rectale. Rapport de l'Association de chirurgie 2003. Monographie, Arnette Edition. September 2003;
  65. Wichmann MW, Hüttl TP, Winter H, et al. Immunological effects of laparoscopic versus open colorectal surgery. Arch Surg. 2005;140:692–697
  66. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315–328
  67. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med. 1996;2:689–692
  68. Peeters CFJM, de Waal RMW, Wobbes T, Westphal JR, Ruers TJM. Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation. Int J Cancer. 2006;119:1249–1253
  69. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–318discussion 318–321
  70. Mala T, Bohler G, Mathisen O, Bergan A, Soreide O. Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome?. World J Surg. 2002;26:1348–1353
  71. Mann CD, Metcalfe MS, Leopardi LN, Maddern GJ. The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg. 2004;139:1168–1172
  72. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Brit J Surg. 2006;93:872–878
  73. O'Rourke TR, Welsh FK, John T, Rees M. Comment on: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Brit J Surg. 2006;93:1434
  74. Verhoef C, Nuytens JJ, Planting AS, de Wilt JH. Comment on: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Brit J Surg. 2007;94:250

PII: S0748-7983(07)00548-3

doi: 10.1016/j.ejso.2007.09.016

European Journal of Surgical Oncology
Volume 33 , Pages S76-S83 , December 2007

Article Tools